Seyfarth Synopsis: On July 14, 2020, Judge James Donato of the U.S. District Court for the Northern District of California became the latest to deny appointment of class counsel in a class action based on lack of diversity,...more
Seyfarth Synopsis: In the latest development in the ultra-high stakes nationwide Prescription Opiate Litigation, the U.S. Court of Appeals for the Sixth Circuit granted the petition for writ of mandamus brought by twelve...more
Seyfarth Synopsis: In complex class actions, courts have looked to Rule 23 to authorize class actions either for trial, or for approval of a previously negotiated settlement. Now as thousands of public entities nationwide...more
9/16/2019
/ Class Action ,
Class Certification ,
Corporate Counsel ,
Drug & Alcohol Abuse ,
Due Process ,
FRCP 23 ,
Manufacturers ,
Multidistrict Litigation ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Pharmacies ,
Public Entities ,
Public Funds ,
Reimbursements